n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Myelopathy in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davies, AL | 1 |
| Desai, RA | 1 |
| Bloomfield, PS | 1 |
| McIntosh, PR | 1 |
| Chapple, KJ | 1 |
| Linington, C | 1 |
| Fairless, R | 1 |
| Diem, R | 1 |
| Kasti, M | 1 |
| Murphy, MP | 1 |
| Smith, KJ | 1 |
1 trial available for n-(3-(aminomethyl)benzyl)acetamidine and Myelopathy
| Article | Year |
|---|---|
Neurological deficits caused by tissue hypoxia in neuroinflammatory disease.
Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental | 2013 |